Advertisement
  • Policy Matters

    Racial and Ethnic Disparities in Multiple Myeloma Clinical Trials

    The AACR and the FDA presented joint recommendations that include broadening clinical trial eligibility and engaging the community in clinical trial recruitment.

    by Kenneth C. Anderson, MD; Lola A. Fashoyin-Aje, MD, MPH; Nicole Gormley, MD; and Paul G. Kluetz, MD

  • Q&A

    Taking the Long View

    In her first book, journalist and breast cancer survivor Kate Pickert traces the winding road of cancer research and patient advocacy.

    by Marci A. Landsmann

  • From the Editor-in-Chief

    Measuring a Cancer Drug’s Effectiveness

    Surrogate endpoints can speed up drug approvals, but are they valid measures of effectiveness?

    by William G. Nelson, MD, PhD

  • Forward Look

    Here Come the Biosimilars

    As patents expire on biologic drugs, cancer patients get new options.

    by Stephen Ornes

  • Survivor Profile

    Sharing Her Strength

    Diagnosed with two cancers prior to turning 40, Rebecca Esparza uses her voice to advocate for policy changes to help people affected by cancer.

    by Lindsey Konkel

  • Robotic Surgery and Cancer

    Using robotic assistants for cancer surgery has become commonplace. Whether cancer patients benefit when a surgeon uses a robot remains unclear.

    by Sue Rochman

  • Parking Costs Take a Hidden Toll on Cancer Patients

    People with cancer can pay significant costs for parking at cancer centers while receiving their treatment, a study finds.

    by Marcus A. Banks

  • A Modern Family

    My diagnosis with colorectal cancer at age 32 affected my fertility. As a result of my experiences, I help others who have been diagnosed with cancer understand their choices related to fertility preservation and their options for becoming a parent.

    by Allison Rosen

  • Pushing Progress Forward

    NCI Director Norman E. “Ned” Sharpless addresses disparities and maps out plans for the future amid “profound upheaval.”

    by Kevin McLaughlin

  • Cancer Care Moves Forward Amid COVID-19

    Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.

    by Kate Yandell